Latest Updates

    None Found

New Studies coming from Seaside Therapeutics.

For anyone who is interested, two Phase 3 Studies of STX209 for Social Withdrawal in Fragile X Syndrome will be starting soon. The initial study will cover ages 12 – 25 with a study covering ages 5-11 following. There will be 20 study sites, including one in Worcester, MA. The studies are not yet recruiting but we will keep you posted.

You can find more information, including a full listing of the study sites, on Seaside’s website or on

Seaside (12-25): (12-25):

Seaside (5-11): (5-11): To Be Announced

Comments are closed.